CR Ventures

CR Ventures is a global life-science investor with a focus on companies entering Phase I or II clinical trials. CR Ventures funds up to 10 clinical programs per year, utilizing a unique investment structure, with an annual capacity of up to $50m in trial costs. CR Ventures offers biotech and medtech companies and their existing investors, more control, less total dilution, and faster results.